8-K
Agape ATP Corp (ATPC)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: February 5, 2026
AGAPE
ATP CORPORATION
(Exact name of registrant as specified in its charter)
| Nevada | 001-41835 | 36-4838886 |
|---|---|---|
| (State<br> or other jurisdiction | (Commission | (IRS<br> Employer |
| of<br> incorporation) | File<br> Number) | Identification<br> No.) |
1705– 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,
TamanDesa, Kuala Lumpur, Malaysia 58100
(Address of principal executive offices) (Zip Code)
+(60) 192230099
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common<br> Stock, par value $0.0001 per share | ATPC | NASDAQ<br> Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously announced on January 29, 2026, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) on January 27, 2026, notifying the Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis for delisting the Company’s securities from Nasdaq.
On February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to delist the Company’s securities. The Staff’s determination was based on that as of January 30, 2026, the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii), the “Low Priced Stocks” Rule.
The Company has the opportunity to request a hearing with the Hearings Panel (the “Panel”), by February 9, 2026. The Company intends to make the request on or prior to February 9, 2026. The hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The fee for the hearing is $20,000.
Item7.01. Regulation FD Disclosure.
On February 5, 2026, the Company issued a press release announcing the delisting notice.
The information contained in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item9.01. Financial Statements and Exhibits
(d) Exhibits.
| Exhibit<br> No. | Description |
|---|---|
| 99.1 | Press Release |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| 2 |
| --- |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AGAPE ATP CORPORATION | ||
|---|---|---|
| Date:<br> February 5, 2026 | By: | /s/ How Kok Choong |
| Name: | How<br> Kok Choong | |
| Title: | Chief<br> Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer) |
| 3 |
| --- |
Exhibit 99.1

PRESSRELEASE
ForImmediate Distribution
AgapeATP Corporation Receives Nasdaq Delisting Notice
KUALALUMPUR, MALAYSIA – 05 FEBRUARY 2026 - Agape ATP Corporation (NASDAQ:ATPC) (“ATPC” or “the Company”) announced that it has received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) regarding the potential delisting of its common stock.
As previously disclosed on 29 January 2026, the Company received a notification from Nasdaq on 27 January 2026 informing the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of US$1.00 per share for continued listing.
Subsequently, on 2 February 2026, the Company received an additional notification from Nasdaq indicating that its securities are subject to delisting under Nasdaq Listing Rule 5810(c)(3)(A)(iii), also known as the “Low Priced Stocks” rule. This determination was based on the Company’s common stock having a closing bid price of US$0.10 or less for ten consecutive trading days as of 30 January 2026.
The Company has the right to request a hearing before the Nasdaq Hearings Panel to appeal the delisting determination. Agape ATP intends to submit its request for a hearing on or before 9 February 2026. The timely filing of the hearing request will stay the suspension of trading of the Company’s securities and the filing of Form 25-NSE, pending the outcome of the hearing.
ATPC will continue to evaluate its options and will provide updates as appropriate.
###
AboutAGAPE ATP Corporation
Agape ATP Corporation (ATPC) is dedicated to enhancing the quality of life and promoting sustainable development. With a strong foundation built on two core business pillars, ATPC specialises in the provision of health and wellness products that caters to the diverse needs of its customers, ensuring their well-being and vitality. Additionally, APTC delivers comprehensive energy-saving solutions that empower companies to drive sustainability initiatives, reduce energy consumption, and achieve their sustainability goals.
For more information, visit www.agapeatpgroup.com.
IssuedBy: Koa International Sdn. Bhd. on behalf of Agape ATP Corporation
MediaContact
JazzminWan
Email: j.wan@swanconsultancy.biz
MandyTan
Email: m.tan@swanconsultancy.biz
SAFEHARBOUR STATEMENT
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the Company’s operational stability, business initiatives, and growth prospects. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “will,” and similar expressions identify forward-looking statements. These statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from those discussed. Factors that may affect results include the Company’s ability to execute its strategies, market acceptance of its products, economic conditions, and other risks detailed in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements except as required by law.
| Page 1 of 1 |
| --- |